Related Experiment Videos
Which coagulation factors interfere with the one-stage prothrombin time?
1Medical Department B, Haukeland Hospital, University of Bergen, Norway.
Haemostasis
|January 1, 1993
Summary
The one-stage prothrombin time (PT) test accurately measures coagulation factors VII and X, but is less reliable for factors II and IX. Factor VII significantly impacts PT results, especially in liver disease or warfarin therapy.
Area of Science:
- Hematology
- Clinical Chemistry
- Coagulation Science
Background:
- The one-stage prothrombin time (PT) is a critical laboratory test for assessing the extrinsic pathway of coagulation.
- Understanding how individual coagulation factors influence PT results is essential for accurate interpretation, particularly in disease states.
- Warfarin therapy and liver disease are known to affect multiple coagulation factors, complicating PT analysis.
Purpose of the Study:
- To investigate the specific responses of the one-stage prothrombin time (PT) to varying activities of key coagulation factors.
- To determine the influence of individual coagulation factors (II, VII, IX, X) on PT measurements.
- To evaluate the impact of multiple coagulation factor deficiencies on PT, particularly in the context of warfarin therapy and liver disease.
Main Methods:
- Experimental investigation of PT activity in response to defined levels of coagulation factors VII, X, IX, and II.
- Analysis of PT in models of multiple coagulation factor deficiencies.
- Comparison of PT results with factor VII levels in patients undergoing warfarin therapy or with liver disease.
Main Results:
- PT demonstrated adequate activity response to coagulation factors VII and X.
- PT showed approximately half the expected activity response to factor IX.
- PT response was less than expected and nonlinear for factor II; PT results closely mirrored factor VII levels in multiple deficiencies, warfarin therapy, and liver disease, with factor VII being the most reduced.
Conclusions:
- The one-stage PT assay is highly sensitive to factor VII activity, which can significantly influence results, especially at high concentrations.
- PT is less reliable for accurately quantifying factors II and IX compared to factors VII and X.
- Factor VII is a primary determinant of PT values in conditions with multiple coagulation factor deficiencies, such as liver disease and warfarin treatment.